Originally posted on HealthCentral

 

  Related Posts

Very big news in the diabetes world today, Folks: the Juvenile Diabetes Research Foundation (JDRF) has announced a partnership with insulin pump makers Animas Corp. (a Johnson & Johnson company) to actually start building the first ready-for-market artificial pancreas, i.e. “a fully automated system to dispense insulin … based on... 

The Juvenile Diabetes Research Foundation announced an innovative partnership with Animas Corporation to develop an automated system to help people with type 1 diabetes better control their disease — the first step on the path to what would be among the most revolutionary advancements in treating type 1 diabetes: the development of an artificial... 

When the  JDRF recently announced its newest artificial pancreas push — a partnership with Animas and Dexcom to actually develop a commercial product — head of the project Aaron Kowalski kindly agreed to answer reader questions here. Today, I bring you those answers, direct “from the horses’ mouth,” as it were. Usage Issues... 

Just five days after JDRF announced it’s partnership with Animas to develop the Artificial Pancreas, another announcement was made on a partnership with Becton, Dickinson and Company, also known as BD, to develop microneedles.  Read More →

JDRF has announced another important step on the road to the development of an artificial pancreas – an automated system to better manage the blood sugar of people with type 1 diabetes – with the establishment of a research program to speed the development of faster-acting insulin…  Read More →

MannKind Corporation (Nasdaq: MNKD) announced that the company will supply its novel, ultra rapid acting insulin AFREZZATM (insulin human [rDNA origin]) for use in a study being conducted by the Juvenile Diabetes Research Foundation (JDRF) as part of its Artificial Pancreas Project…  Read More →

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and the Juvenile Diabetes Research Foundation (JDRF) announced a unique partnership to develop therapeutic treatments for people with type 1 diabetes at different stages of the disease — both those living with the disease and the newly diagnosed — as well as preventing diabetes in those at risk…  Read More →

I know, I know, I had the same reaction: What the heck?! Just on the heels of the Juvenile Diabetes Research Foundation (JDRF)’s big artificial pancreas announcement last week that brings the non-profit into a commercial partnership with J&J, yesterday they released news of a new commercial partnership with Becton Dickinson (BD). The goal... 

An article published Online First and in an upcoming edition of The Lancet reports that the use of ‘artificial pancreas’ closed-loop insulin delivery systems can improve blood sugar control in patients with type 1 diabetes. In these systems the insulin is delivered in response to changing blood sugar levels…  Read More →

Much buzz has been going around the diabetes community about the recent announcement of the JDRF/Animas partnership to develop a “first generation artificial pancreas”, and rightly so. The ability to eat like a “normal person”, to not have to worry about debilitating highs and lows, to be able to sleep without fear of not... 

  Related Tweets from Twitter

  Related News from Digg